Evidence map›Paper›PMID 19318206›Full record

ArticleChemistry & biology2009

Designing new cellular signaling pathways.

Peter M Pryciak

Abstract read
In one paragraph

Article in Chemistry & biology, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed.

  1. Review
  2. Review
  3. Signal transduction: From the atomic age to the post-genomic era.Cold Spring Harbor perspectives in biology · 2014
    Review
  4. Protein design for pathway engineering.Journal of structural biology · 2014
    Review
  5. Article
  6. Article
  7. Article
  8. Mapping the life histories of T cells.Nature reviews. Immunology · 2010
    Review
  9. Designing customized cell signalling circuits.Nature reviews. Molecular cell biology · 2010
    Review
  10. Article
  11. Strategies for protein synthetic biology.Nucleic acids research · 2010
    Review
  12. Review
  13. Review
  14. Article
  15. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author.

Peter M PryciakDepartment of Molecular Genetics & Microbiology, and Program in Cell Dynamics, University of Massachusetts Medical School, Worcester, MA 01605,USA. peter.pryciak@umassmed.edu

Funding

YEAST PHEROMONE SIGNAL TRANSDUCTIONR01GM057769 · NIGMS · UNIV OF MASSACHUSETTS MED SCH WORCESTER · PI PRYCIAK, PETER M · 1997 to 2023
$7.6M
NIGMS NIH HHS R01 GM057769
6 · The paper itself

Abstract

All cells respond to signals from the environment. Extracellular stimuli activate intracellular signal transduction pathways that make decisions about cell identity, behavior, and survival. A nascent field aims to design and construct new signaling pathways beyond those found in nature. Current strategies exploit the structural modularity of many signaling proteins, which makes them inherently amenable to domain-swapping tactics that exchange their input and output connections. The results reveal a remarkable degree of functional plasticity in signaling proteins and pathways, as well as regulatory logic that can be transported to new proteins. Modified adaptor and scaffold proteins can reroute signal traffic and adjust the response behavior of the pathway circuit. These synthetic biology approaches promise to deepen our understanding of existing signaling pathways and spur the development of new cellular tools for research, industry, and medicine.

Indexed as

Protein EngineeringSignal TransductionBiomimeticsModels, BiologicalProteinsProtein Structure, TertiaryProteins

Identifiers

PMID19318206
PMCPMC2661875

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.